Chengtian (程天科技 / RoboCT)
Hangzhou, ChinaSee on the mapFounded 2017
- Neurorehabilitation and assistive tech
- Wearables
- Series B
RoboCT is a robotics company founded in 2017 that develops exoskeleton technology, including core algorithms and components. Focused on rehabilitation and elder care, it provides assistive and rehabilitation products for healthcare institutions and individuals, combining human–machine interaction, AI, data analysis, and cloud computing.
- RaisedTotal raised
- $77.8M
- Mar 2026Latest priced round, Mar 2026
- Series B
- Investors
- 9
- Founded
- 2017
reccy insights
RoboCT’s clearest recent milestone is its reported Series B financing activity in 2025 and 2026. A $14M Series B is dated March 13, 2025, followed by a $14.2M Series B1 dated January 6, 2026. Additional Series B and Series B+ entries are listed in March 2026, including a $14M B+ round naming Hangzhou Capital, ABC Capital, and Inovance Industry Investment, and a separate $9.44M Series B entry dated March 5. The company’s stated valuation is $55M as of March 2026. These financing details contain overlapping round labels and amounts, so the sequence should be treated cautiously. On the product and technology side, RoboCT develops rehabilitation and mobility-assistance exoskeletons, joint modules, motion-control solutions, and its UAO rehabilitation and assessment system. Its website analysis also describes more than 350 independently owned intellectual property items and over 20 developed products.
Written by reccy's AI from company sites, press and funding records · updated Nov 2026
What makes Chengtian (程天科技 / RoboCT) distinct
- 01Develops exoskeleton systems as well as core components such as joint modules and motion-control solutions.
- 02Addresses rehabilitation, mobility assistance, and elder-care needs for both healthcare institutions and individual users.
- 03Reports more than 350 independently owned intellectual property items and over 20 developed products.
- 04Operates a dedicated production facility for exoskeleton robots and core robotic components.
- 05Collaborates with universities on research and development, including interactive rehabilitation exoskeletons.
Technology & products4
- Rehabilitation and mobility-assistance exoskeletons
Wearable robotic systems for rehabilitation, mobility assistance, and personal care.
- Joint modules
Integrated robotic components combining brushless servo motors, drives, gear reducers, and encoders.
- Mecanum wheel modules
Omnidirectional mobility systems for robotic applications.
+ 1 more: UAO integrated rehabilitation and assessment system
Recent updates1
- Nov 11, 2026Award
喜讯!程天科技获评“2026 年度浙江省省级工业设计中心”
roboct.com
Funding
- Series BMar 2026$9.4M
- Series B1Jan 2026$14.2M
- Series BMar 2025$14MLed by Guolian Group
Similar companies
About Chengtian (程天科技 / RoboCT)
- Products
- Rehabilitation and mobility-assistance exoskeletons, Joint modules, Mecanum wheel modules, UAO integrated rehabilitation and assessment system
- Focus areas
- Exoskeleton robotics, rehabilitation, assistive technology, elder care, medical robotics, AI, wearables, robotics hardware
- Headquarters
- Hangzhou, China
- Founded
- 2017